BANGKOK, THAILAND – Wattanosoth Cancer Hospital (Bangkok Cancer Hospital) is proud to announce its landmark achievement as the world’s first facility to reach ICHOM Level 2 accreditation for Breast Cancer Care. This prestigious recognition, awarded by the International Consortium for Health Outcomes Measurement (ICHOM), solidifies the hospital’s position as a global leader in value-based healthcare.
Setting a New Global Standard in Patient-Centered Care
A Revolution in Patient-Centered Outcomes by implementing the ICHOM Standard Set, Wattanosoth Cancer Hospital has revolutionized its Breast Cancer Pathway, moving beyond traditional clinical metrics to focus on what matters most to patients: quality of life and long-term recovery.
“Our partnership with ICHOM has been the cornerstone of our transition to a truly value-based model,” says the hospital’s clinical leadership. “It has helped us achieve our goal of standardizing care protocols while ensuring every decision is guided by real-world patient data”.
The hospital’s data-driven approach monitors critical patient-reported outcomes (PROMs), including:
- Survival and Disease Control: Achieving a remarkable 98% 5-year relative survival rate for localized breast cancer, surpassing international SEER benchmarks.
- Degree of Health: Tracking 20 essential measurements such as physical, emotional, and social functioning to ensure holistic recovery.
- Disutility of Care: Actively monitoring and minimizing complications and the impact of treatments like surgery and chemotherapy.
A Legacy of Excellence and Innovation
This accreditation is the latest in a series of international honors for the hospital, including being named one of the “Best Specialized Hospitals in Asia Pacific 2025” by Newsweek and receiving the Healthcare Asia Award 2025. As part of the Bangkok Dusit Medical Services (BDMS) network, Wattanosoth Cancer Hospital utilizes advanced technologies like Power BI for real-time monitoring of patient outcomes, ensuring every individual receives world-class, compassionate care.
“Our care is beyond curing,” says the Wattanosoth team. “This ICHOM accreditation reflects our dedication to empowering safer lives and sustainable well-being for all our patients.”
About Wattanosoth Cancer Hospital
Located at the Bangkok Hospital Headquarters, Wattanosoth Cancer Hospital is a specialized facility dedicated to pioneering cancer treatments. With a multidisciplinary team of experts and a commitment to international standards, it continues to lead the way in oncology across the Asia Pacific region.
Impact on Stakeholders
The greatest impact of this partnership has been the empowerment of patients and families. By involving them in the “Care Beyond Cure” philosophy, the hospital ensures that treatment plans are equitable and tailored to individual needs. This dedication has earned Wattanosoth the Healthcare Asia Award 2025 and recognition as one of the “Best Specialized Hospitals in Asia Pacific” by Newsweek.
“Our care is beyond curing; it is about a sustainable well-being for all,”.
